基质金属蛋白酶在健康与疾病中的作用 3.0 版。
Matrix Metalloproteinases in Health and Disease 3.0.
机构信息
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.
Interuniversity Center of Phlebolymphology (CIFL), "Magna Graecia" University, 88100 Catanzaro, Italy.
出版信息
Biomolecules. 2024 Aug 26;14(9):1059. doi: 10.3390/biom14091059.
Abstract
Matrix metalloproteinases (MMPs) are members of an enzyme family that are critical for maintaining tissue allostasis [...].
摘要
基质金属蛋白酶（MMPs）是一类酶家族的成员，对于维持组织内稳态至关重要[... ]。
相似文献
1
Matrix Metalloproteinases in Health and Disease 3.0.基质金属蛋白酶在健康与疾病中的作用 3.0 版。
Biomolecules. 2024 Aug 26;14(9):1059. doi: 10.3390/biom14091059.
2
Matrix Metalloproteinases in Health and Disease.基质金属蛋白酶在健康和疾病中的作用。
Biomolecules. 2020 Aug 1;10(8):1138. doi: 10.3390/biom10081138.
3
Matrix metalloproteinases in skeletal muscles: friends or foes?骨骼肌中的基质金属蛋白酶：是敌是友？
Neurobiol Dis. 2012 Dec;48(3):508-18. doi: 10.1016/j.nbd.2012.07.023. Epub 2012 Aug 3.
4
Matrix metalloproteinases (MMPs) in health and disease: an overview.健康与疾病中的基质金属蛋白酶（MMPs）：综述
Front Biosci. 2006 May 1;11:1696-701. doi: 10.2741/1915.
5
Matrix Metalloproteinases in Health and Disease 2.0.基质金属蛋白酶在健康与疾病中的作用 2.0 版
Biomolecules. 2022 Aug 27;12(9):1190. doi: 10.3390/biom12091190.
6
Role of Matrix Metalloproteinases in Degenerative Kidney Disorders.基质金属蛋白酶在退行性肾脏疾病中的作用。
Curr Med Chem. 2018;25(15):1805-1816. doi: 10.2174/0929867325666171205143441.
7
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.基质金属蛋白酶与金属蛋白酶组织抑制剂：结构、功能及生物化学
Circ Res. 2003 May 2;92(8):827-39. doi: 10.1161/01.RES.0000070112.80711.3D.
8
Matrix metalloproteinases and atherosclerosis.基质金属蛋白酶与动脉粥样硬化
Curr Atheroscler Rep. 2004 Mar;6(2):112-20. doi: 10.1007/s11883-004-0099-1.
9
[The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].[金属蛋白酶在侵袭性肿瘤生长、转移和血管生成过程中对细胞外基质修饰的作用]
Postepy Hig Med Dosw (Online). 2012 Sep 10;66:609-28. doi: 10.5604/17322693.1009705.
10
Matrix Metalloproteinases and Platelet Function.基质金属蛋白酶与血小板功能
Prog Mol Biol Transl Sci. 2017;147:133-165. doi: 10.1016/bs.pmbts.2017.01.002. Epub 2017 Mar 21.
引用本文的文献
1
Limited Proteolysis as a Regulator of Lymphatic Vessel Function and Architecture.有限蛋白水解作为淋巴管功能和结构的调节因子
Int J Mol Sci. 2025 Jul 24;26(15):7144. doi: 10.3390/ijms26157144.
2
Potential target within the tumor microenvironment - MT1-MMP.肿瘤微环境中的潜在靶点——基质金属蛋白酶1（MT1-MMP）
Front Immunol. 2025 Mar 24;16:1517519. doi: 10.3389/fimmu.2025.1517519. eCollection 2025.
3
Identification of Alterations in the Expression of Genes Related to the Implant Failure in Spanish Patients with Down Syndrome and Periodontal Disease.西班牙唐氏综合征和牙周病患者种植失败相关基因表达变化的鉴定
Genes (Basel). 2025 Jan 22;16(2):122. doi: 10.3390/genes16020122.
本文引用的文献
1
Expression of , , and genes in aortic dissection.、、和基因在主动脉夹层中的表达。
Exp Ther Med. 2024 Jul 10;28(3):360. doi: 10.3892/etm.2024.12649. eCollection 2024 Sep.
2
Comprehending the pharmacological mechanism of marine phenolic acids in bladder cancer therapy against matrix metalloproteinase 9 protein by integrated network pharmacology and in-silico approaches.综合网络药理学和计算方法理解海洋酚酸类化合物通过基质金属蛋白酶 9 蛋白治疗膀胱癌的药理机制。
Comput Biol Chem. 2024 Oct;112:108149. doi: 10.1016/j.compbiolchem.2024.108149. Epub 2024 Jul 14.
3
ADAM15 in Fibroblasts: Improving the Matrix Remodeling by Blocking the Action of Transforming Growth Factor-β1.ADAM15 在成纤维细胞中的作用：通过阻断转化生长因子-β1 的作用来改善基质重塑。
Ann Clin Lab Sci. 2024 May;54(3):363-370.
4
Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells.组织金属蛋白酶抑制剂 3（TIMP3）突变增加了 RPE 细胞的糖酵解活性，并使谷氨酰胺代谢失调。
Mol Metab. 2024 Oct;88:101995. doi: 10.1016/j.molmet.2024.101995. Epub 2024 Jul 22.
5
Molecular immunological mechanisms of impaired wound healing in diabetic foot ulcers (DFU), current therapeutic strategies and future directions.糖尿病足溃疡（DFU）中伤口愈合受损的分子免疫机制、当前的治疗策略和未来方向。
Int Immunopharmacol. 2024 Sep 30;139:112713. doi: 10.1016/j.intimp.2024.112713. Epub 2024 Jul 23.
6
Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression.打破循环：基质金属蛋白酶抑制剂作为一种治疗结核病发病机制和进展的替代方法。
ACS Infect Dis. 2024 Aug 9;10(8):2567-2583. doi: 10.1021/acsinfecdis.4c00385. Epub 2024 Jul 22.
7
miR-126a-5p inhibits H1N1-induced inflammation and matrix protease secretion in lung fibroblasts by targeting ADAMTS-4.miR-126a-5p 通过靶向 ADAMTS-4 抑制 H1N1 诱导的肺成纤维细胞炎症和基质蛋白酶分泌。
Arch Virol. 2024 Jul 11;169(8):164. doi: 10.1007/s00705-024-06086-4.
8
The effect of ADAMTS13 on graft-versus-host disease.ADAMTS13 对移植物抗宿主病的影响。
J Cell Mol Med. 2024 Jul;28(13):e18457. doi: 10.1111/jcmm.18457.
9
Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression.没食子酰基 Bergenin 通过降低 Galectin-3 和 MMP-9 的表达抑制人宫颈癌细胞的生长。
Sci Rep. 2024 Jul 3;14(1):15287. doi: 10.1038/s41598-024-64781-3.
10
Metalloproteinases as Biomarkers and Sociomarkers in Human Health and Disease.金属蛋白酶作为人类健康和疾病的生物标志物和社会标志物。
Biomolecules. 2024 Jan 11;14(1):96. doi: 10.3390/biom14010096.
Zotero 插件